Medicare Compliance & Reimbursement
Momentum Builds To Reopen Medicare Law
Two Senators who voted for the Medicare bill, one Republican and one Democrat, have joined those who are pushing to remove the legislation's "noninterference" clause. That provision prohibits the government from using its purchasing clout to obtain lower drug prices from pharmaceutical companies.
In their Medicare Enhancements for Needed Drugs Act, unveiled Feb. 5, Sens. Olympia Snowe (R-ME) and Ron Wyden (D-OR) also propose to withhold tax deductions for advertising expenses from drugmakers that restrict deliveries to foreign wholesalers and pharmacists to prevent them from reselling the medications to Americans. Additionally, the MEND Act would provide higher payments to private plans that negotiate lower drug prices for seniors.
Snowe and Wyden also want the General Accounting Office to begin monitoring drug prices. This part of their proposal is aimed at fears that pharmaceutical companies will raise prices before the Medicare drug benefit starts in 2006 to give them a higher base from which to negotiate discounts.
At a Feb. 6 reporters' breakfast, Senate Majority Leader Bill Frist (R-TN) pointed to the Congressional Budget Office's conclusion that removing the noninterference clause would not save money because the private plans the Medicare bill relies on will be able to negotiate better discounts than the government could get. Frist also reminded reporters that noninterference language has appeared in Democratic Medicare bills, such as legislation introduced by Senate Minority Leader Tom Daschle (D-SD) in 2000.
Medicare Compliance & Reimbursement
- Medicare Advantage:
MedAdv Plans Lower Premiums, Enhance Benefits
Flush with federal funding, plans are making their products more attractive.
Less than a month after [...] - CMS Administration:
$1 Billion Not Enough To Implement New Law?
Responsible for revamping Medicare in two years, CMS is swamped.
Saying that their agency is swamped, [...] - Medicare Reform Law:
Momentum Builds To Reopen Medicare Law
Democrats want cheaper drugs, Republicans want cheaper Medicare.
Two Senators who voted for the Medicare bill, [...] - DME:
New Coalition Opposes Wheelchair Policy Changes
CMS tries to sneak in drastic changes through backdoor policy-making.
The durable medical equipment industry is [...] - Home Care:
Home Care Cuts On The Horizon
Increased Medicare bill cost estimate puts HHAs at risk.
Just when home health agencies are taking [...] - Regulation:
Got A Beef With CMS? Make Yourself Heard
It's easier than ever to give your 2 cents' worth on CMS' proposals.
Health care providers [...] - Politics:
GOP-Connected Firm Big Player On Medicare Ads
Are the new TV spots public service announcements or Bush reelection
Alexandria VA-based National Media Inc. [...] - Labs:
OIG Eyes State Lab Payment Policies
Audit could affect lab payments.
The HHS Office of Inspector General says the state of Massachusetts [...] - Pharmaceuticals:
Reimbursement Rates For Popular Meds Under Fire
OIG report claims Medicare is paying higher rates, losing millions.
Payments for widely used pharmaceuticals could [...] - Program Memo Roundup:
The interest rate for Medicare overpayments and underpayments will remain steady at 12 percent, the [...] - Bill Watch:
Bill introduced in the House: HR 3711. A bill to amend the Medicare Prescription Drug, [...]
